About
Retinal Gene Therapy Treatments
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide Therapy
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
228
By Phase
PHASE1/PHASE2: 1NA: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT05748873Lead Sponsor
Promising ROd-cone DYstrophy Gene therapY
PHASE1/PHASE2Recruiting
33 participants
Started: Apr 12, 2023 · Completed: Sep 30, 2030
NCT04285398Lead Sponsor
Prospective Natural History Study of Retinitis Pigmentosa
NAActive, not recruiting
82 participants
Started: Feb 12, 2020 · Completed: Jun 30, 2026
NCT03975543Lead Sponsor
Retrospective Natural History Study of Retinitis Pigmentosa
N/AUnknown
113 participants
Started: Oct 1, 2018 · Completed: Sep 30, 2021
Locations (1)
Headquarters
Paris, France
Map
Loading map...